ArticleJCO precision oncology2022

Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion.

Marina Gaule et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.